Vanguard Group
XGN icon

Vanguard Group’s Exagen XGN Stock Holding History

Vanguard Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.8M Buy
790,011
+56,187
+8% +$511K ﹤0.01% 3268
2025
Q3 		$8.06M Buy
733,824
+52,205
+8% +$462K ﹤0.01% 3092
2025
Q2 		$4.76M Buy
681,619
+190,675
+39% +$1.16M ﹤0.01% 3234
2025
Q1 		$1.76M Hold
490,944
– – ﹤0.01% 3531
2024
Q4 		$2.01M Hold
490,944
– – ﹤0.01% 3563
2024
Q3 		$1.52M Hold
490,944
– – ﹤0.01% 3643
2024
Q2 		$894K Hold
490,944
– – ﹤0.01% 3824
2024
Q1 		$781K Hold
490,944
– – ﹤0.01% 3889
2023
Q4 		$977K Hold
490,944
– – ﹤0.01% 3835
2023
Q3 		$1.19M Hold
490,944
– – ﹤0.01% 3766
2023
Q2 		$1.42M Hold
490,944
– – ﹤0.01% 3782
2023
Q1 		$1.19M Hold
490,944
– – ﹤0.01% 3864
2022
Q4 		$1.18M Buy
490,944
+167
+0% +$428 ﹤0.01% 3852
2022
Q3 		$1.33M Hold
490,777
– – ﹤0.01% 3905
2022
Q2 		$2.82M Sell
490,777
-46,360
-9% -$270K ﹤0.01% 3655
2022
Q1 		$4.31M Sell
537,137
-2,960
-0.5% -$25.5K ﹤0.01% 3603
2021
Q4 		$6.28M Buy
540,097
+29,892
+6% +$350K ﹤0.01% 3489
2021
Q3 		$6.94M Sell
510,205
-9,668
-2% -$129K ﹤0.01% 3458
2021
Q2 		$7.79M Buy
519,873
+106,908
+26% +$1.64M ﹤0.01% 3341
2021
Q1 		$7.23M Buy
412,965
+97,523
+31% +$1.74M ﹤0.01% 3339
2020
Q4 		$4.16M Buy
315,442
+547
+0.2% +$7.73K ﹤0.01% 3439
2020
Q3 		$3.41M Sell
314,895
-360
-0.1% -$4.64K ﹤0.01% 3320
2020
Q2 		$3.91M Buy
315,255
+34,214
+12% +$463K ﹤0.01% 3208
2020
Q1 		$4.48M Buy
281,041
+35,958
+15% +$714K ﹤0.01% 3013
2019
Q4 		$6.23M Buy
245,083
+210,083
+600% +$3.74M ﹤0.01% 3092
2019
Q3 		$542K Buy
+35,000
New +$565K ﹤0.01% 3798

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Vanguard Group's XGN Position: Q4 2025 in Review

Vanguard Group increased its Exagen (XGN) stake by 7.7% in Q4 2025, buying an estimated $511K and bringing the position to 790,011 shares worth $4.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3268.

Vanguard Group first reported a position in XGN in Q3 2019 and has held it in 26 quarters since. The position peaked at $8.06M in Q3 2025. 80 funds tracked by Wall St. Rank hold XGN as of Q4 2025.

  • Vanguard Group held 790,011 shares of Exagen worth $4.8M as of Q4 2025.
  • Vanguard Group bought 56,187 Exagen shares in Q4 2025, an estimated $511K.
  • Exagen made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3268 holding.
  • Vanguard Group first reported a position in Exagen in Q3 2019 and has held it in 26 quarters since.
  • Vanguard Group's Exagen position peaked at $8.06M in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Exagen as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.